1. Home
  2. ASYS vs GANX Comparison

ASYS vs GANX Comparison

Compare ASYS & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASYS
  • GANX
  • Stock Information
  • Founded
  • ASYS 1981
  • GANX 2017
  • Country
  • ASYS United States
  • GANX United States
  • Employees
  • ASYS N/A
  • GANX N/A
  • Industry
  • ASYS Industrial Machinery/Components
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASYS Technology
  • GANX Health Care
  • Exchange
  • ASYS Nasdaq
  • GANX Nasdaq
  • Market Cap
  • ASYS 59.4M
  • GANX 51.8M
  • IPO Year
  • ASYS N/A
  • GANX 2021
  • Fundamental
  • Price
  • ASYS $4.56
  • GANX $1.44
  • Analyst Decision
  • ASYS
  • GANX Strong Buy
  • Analyst Count
  • ASYS 0
  • GANX 5
  • Target Price
  • ASYS N/A
  • GANX $8.20
  • AVG Volume (30 Days)
  • ASYS 38.6K
  • GANX 276.2K
  • Earning Date
  • ASYS 08-15-2025
  • GANX 08-11-2025
  • Dividend Yield
  • ASYS N/A
  • GANX N/A
  • EPS Growth
  • ASYS N/A
  • GANX N/A
  • EPS
  • ASYS N/A
  • GANX N/A
  • Revenue
  • ASYS $90,826,000.00
  • GANX N/A
  • Revenue This Year
  • ASYS N/A
  • GANX N/A
  • Revenue Next Year
  • ASYS $28.60
  • GANX N/A
  • P/E Ratio
  • ASYS N/A
  • GANX N/A
  • Revenue Growth
  • ASYS N/A
  • GANX N/A
  • 52 Week Low
  • ASYS $3.20
  • GANX $0.89
  • 52 Week High
  • ASYS $6.81
  • GANX $3.19
  • Technical
  • Relative Strength Index (RSI)
  • ASYS 49.82
  • GANX 34.87
  • Support Level
  • ASYS $4.50
  • GANX $1.55
  • Resistance Level
  • ASYS $4.77
  • GANX $1.72
  • Average True Range (ATR)
  • ASYS 0.27
  • GANX 0.12
  • MACD
  • ASYS -0.03
  • GANX -0.02
  • Stochastic Oscillator
  • ASYS 41.26
  • GANX 6.12

About ASYS Amtech Systems Inc.

Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: